New Phospho-Epitope Mapping

Trouble viewing? Read the online version.

We're thrilled to announce that PEPperPRINT now launches PEPperCHIP^® Phosphorylated Peptide Microarrays with up to 24,000 different peptides per chip. Thanks to the new and proprietary cLIFT technology, you can study from now on the role and effects of selective phosphorylation in your protein of interest. This is exemplified by a recent epitope mapping of a phosphospecific antibody against tau protein which showed a clear epitope including phospho-T547, while the non-phosphorylated variant exhibited a threefold weaker signal.

Contact us to learn more about how we can help advance your research with our PEPperCHIP^® Phosphorylated Peptide Microarrays and phospho-epitope mapping services.

Get in touch

Evaluation of tumor antigen-specific antibody responses

Antibody responses to tumor antigens

Researchers at the UNC at Chapel Hill investigated the role of B cells antitumor immunity and their association with response to immunotherapy in patients with metastatic triple negative breast cancer.
Read the paper

ACCR Annual Meeting is here!

We're excited to be part of this year's American Association for Cancer Research Annual Meeting 2023 taking place at the Orange County Convention Center in Orlando. Drop by our booth #1269 and chat with us on April 14-19.
About AACR 2023

Watch our latest webinar video

Dr. Leibly presented his work identifying and targeting unconventional druggable sites on pathological amyloid fibrils. Peptide microarrays were used for rapid screening and discovery of such peptides.
Watch the webinar

Connect with us on social media

Communications Policy
This email is delivered in accordance with the EU Directive on Privacy and Electronic Communications. We respect your online privacy. You are receiving this email because we feel it may be of relevance to you or you are already a PEPperPRINT customer. It you don't want to receive this email anymore, you can unsubscribe at any time.